via
respiratori
tract
caus
sever
acut
respiratori
distress
syndrom
infect
lung
epitheli
cell
macrophag
macrophag
readili
recogn
viru
elimin
merscov
infect
cell
via
spike
glycoprotein
bind
dipeptidylpeptidas
receptor
present
macrophag
whether
associ
affect
macrophag
respons
remain
unknown
herein
demonstr
infect
macrophag
lentivir
particl
pseudotyp
merscov
glycoprotein
result
suppress
macrophag
respons
sinc
reduc
capac
macrophag
produc
naiv
lpsactiv
macrophag
augment
lpsinduc
product
immunosuppress
cytokin
merscov
glycoprotein
induc
express
neg
regul
tlr
signal
irakm
well
transcript
repressor
inhibit
inhibitor
sitagliptin
sirna
abrog
effect
merscov
glycoprotein
irakm
confirm
immunosuppress
effect
mediat
receptor
effect
observ
macrophag
human
primari
peripher
blood
monocyt
find
support
suppress
action
merscov
macrophag
suggest
potenti
target
effect
elimin
pathogen
middl
east
respiratori
syndrom
corona
viru
merscov
positivesens
singlestrand
rna
betacoronaviru
relat
sever
acut
respiratori
syndrom
coronaviru
sarscov
merscov
identifi
human
first
time
kingdom
saudi
arabia
june
case
associ
death
confirm
http
wwwwhointcsrdiseasecoronaviru
infectionsarchiveupdatesen
singl
export
case
travel
histori
middl
east
result
ongo
outbreak
republ
korea
merscov
case
also
detect
europ
usa
asia
africa
clinic
featur
merscov
infect
vari
asymptomat
case
sever
lower
respiratori
tract
infect
shock
multiorgan
failur
may
lead
death
viru
spread
persontoperson
although
rate
transmiss
appear
low
probabl
due
low
percentag
respiratori
oncotarget
wwwimpactjournalscomoncotarget
epitheli
cell
truli
infect
merscov
increas
number
viral
particl
like
need
inhal
caus
infect
among
major
structur
compon
spike
glycoprotein
express
merscov
review
play
import
role
viral
attach
entri
target
cell
merscov
glycoprotein
contain
amino
acid
appear
trimer
viral
membran
surfac
precursor
protein
cleav
two
subunit
subunit
contain
receptorbind
domain
rbd
respons
bind
cellular
receptor
dipeptidylpeptidas
subunit
consist
put
fusion
peptid
transmembran
domain
two
heptad
repeat
region
term
heptad
repeat
mediat
membran
fusion
merscov
infect
mediat
bind
viral
glycoprotein
cognat
receptor
dipeptidyl
peptidas
typeii
transmembran
glycoprotein
wide
express
non
ciliat
bronchial
epithelium
macrophag
determin
host
rang
cellular
tropism
locat
rbd
region
glycoprotein
crystal
structur
model
reveal
amino
acid
residu
receptor
critic
implic
bind
receptor
present
differ
cell
type
infect
viru
includ
macrophag
whether
interact
glycoprotein
alter
macrophag
respons
remain
unknown
recent
evid
shown
merscov
induc
immunosuppress
escap
host
immun
surveil
partli
promot
tcell
apoptosi
merscov
glycoprotein
viral
compon
capabl
induc
immun
respons
protein
shown
induc
potent
neutral
antibodi
respons
result
inhibit
infect
differ
model
mean
spike
protein
express
term
innat
immun
immunemodulatori
mechan
induc
merscov
glycoprotein
explor
far
macrophag
infect
viru
viru
abl
replic
within
cell
present
studi
investig
impact
merscov
glycoprotein
respons
monocyt
macrophag
stimul
purpos
lentivir
particl
express
mer
glycoprotein
construct
effect
lpsinduc
respons
evalu
viru
unabl
replic
provid
uniqu
tool
defin
impact
mer
glycoprotein
interact
cell
activ
result
show
mer
cov
glycoprotein
suppress
product
tnfa
augment
product
time
induc
express
neg
regul
tlr
signal
irakm
transcript
repressor
treatment
inhibitor
sitagliptin
revers
effect
merscov
glycoprotein
macrophag
determin
effect
merscov
glycoprotein
macrophag
activ
gener
pseudoviru
express
hiv
backbon
link
luciferas
gene
merscov
protein
vector
follow
transfect
respect
construct
cell
lentivir
particl
pseudotyp
merscov
glycoprotein
carri
mutat
protein
inhibit
associ
receptor
also
gener
use
neg
control
express
mer
cov
protein
supernat
confirm
western
blot
figur
left
panel
supernat
collect
transfect
cell
use
normal
protein
infect
cell
primari
monocyt
subsequ
experi
confirm
presenc
viru
infect
infect
cell
harvest
lyse
luciferas
activ
measur
protein
lysat
figur
right
panel
significantli
increas
viral
entri
viral
particl
pseudotyp
merscov
express
wildtyp
spike
glycoprotein
compar
mutant
spike
protein
success
confirm
envelop
success
enter
target
cell
previous
describ
monocyt
express
level
increas
upon
differenti
macrophag
pma
ligand
glycoprotein
lp
treatment
affect
level
macrophag
supplematari
figur
macrophag
deriv
follow
pma
treatment
infect
lentivir
particl
carri
wildtyp
wt
mutant
merscov
protein
mockinfect
twentyfour
hour
post
infect
cell
stimul
lp
level
measur
exposur
macrophag
lentivir
particl
express
mer
cov
protein
result
suppress
lpsinduc
product
figur
wildtyp
merscov
protein
also
suppress
basal
product
macrophag
figur
even
though
level
approach
detect
limit
assay
assess
whether
lentivir
particl
express
merscov
protein
affect
macrophag
surviv
prolifer
thu
perform
mtt
assay
oncotarget
wwwimpactjournalscomoncotarget
pseudotyp
mer
glycoprotein
gener
cell
follow
transfect
plasmid
contain
merscov
wildtyp
mutant
spike
glycoprotein
normal
supernat
use
infect
cell
infect
monitor
luciferas
assay
merscov
spike
glycoprotein
detect
western
blot
purifi
lentivir
particl
envelop
protein
use
normal
control
semiquantit
analysi
merscov
protein
among
differ
type
pseudotyp
virus
macrophag
infect
lentivir
particl
pseudotyp
mer
wild
type
wt
mutant
glycoprotein
merscov
left
uninfect
mock
stimul
lp
measur
supernat
state
b
follow
lp
stimul
c
also
measur
lpstreat
macrophag
e
p
p
oncotarget
wwwimpactjournalscomoncotarget
macrophag
infect
letiviru
express
merscov
glycoprotein
hour
result
show
lentivir
particl
express
merscov
glycoprotein
affect
macrophag
surviv
prolifer
even
though
small
decreas
prolifer
observ
mutant
wt
glycoproteinconta
particl
due
infect
process
supplementari
figur
major
immunosuppress
cytokin
dampen
innat
adapt
immun
respons
exposur
macrophag
particl
express
wildtyp
merscov
glycoprotein
augment
lpsinduc
mrna
macrophag
figur
accordingli
infect
lentivir
particl
carri
wild
type
protein
augment
lpsinduc
protein
secret
figur
support
increas
immunosuppress
capac
macrophag
expos
merscov
glycoprotein
magnitud
macrophag
activ
regul
multipl
factor
includ
transcript
factor
known
suppress
product
cytokin
irakm
inact
irak
kinas
isoform
known
suppress
tlr
signal
exposur
macrophag
lentivir
particl
carri
merscov
glycoprotein
result
induct
irakm
figur
figur
express
suggest
potenti
mechan
immunosuppress
action
exposur
cell
lentivir
particl
differ
time
point
reveal
irakm
induc
hour
follow
infect
earlier
suggest
immediateearli
effect
may
affect
macrophag
respons
later
stage
infect
figur
test
whether
amount
glycoprotein
affect
irakm
induct
perform
serial
dilut
lentivir
particl
contain
either
wild
type
mutant
glycoprotein
infect
macrophag
measur
irakm
reduc
amount
spike
infect
medium
fail
induc
irakm
supplementari
figur
merscov
glycoprotein
bind
receptor
determin
whether
induct
neg
regul
macrophag
activ
irakm
depend
signal
initi
interact
merscov
glycoprotein
treat
macrophag
enzymat
inhibitor
sitagliptin
expos
lentivir
particl
carri
merscov
wildtyp
mutant
glycoprotein
result
confirm
inhibit
signal
amelior
induct
irakm
figur
figur
figur
wildtyp
merscov
glycoprotein
interestingli
inhibitor
augment
lpsinduc
express
expect
antiinflammatori
properti
confirm
irakm
induc
via
interact
glycoprotein
use
sirna
approach
knockdown
macrophag
prior
infect
supplementari
figur
result
show
knockdown
amelior
induct
irakm
glycoprotein
figur
sinc
irakm
induc
glycoprotein
macrophag
decid
check
whether
effect
glycoprotein
product
mediat
irakm
figur
follow
knockdown
cell
infect
lentivir
particl
contain
either
wild
type
mutant
glycoprotein
mock
infect
prior
stimul
lp
result
show
knockdown
irakm
revers
effect
wt
glycoprotein
figur
figur
suppress
augment
lpsinduc
product
cell
infect
letivir
particl
carri
wt
glycoprotein
support
import
neg
regul
express
confirm
find
primari
human
cell
isol
primari
human
monocyt
healthi
donor
infect
lentivir
particl
carri
merscov
wildtyp
mutant
glycoprotein
pbmc
express
high
level
supplementari
figur
receptor
mer
cov
glycoprotein
result
confirm
find
cell
show
lentivir
particl
carri
merscov
wildtyp
protein
suppress
basal
lpsinduc
product
figur
augment
lpsinduc
secret
figur
addit
lentivir
particl
carri
merscov
wildtyp
protein
induc
express
irakm
mrna
protein
figur
induc
protein
level
figur
induct
irakm
amelior
presenc
inhibitor
sitagliptin
figur
merscov
infect
associ
sever
ard
increas
mortal
infect
individu
infect
sever
cell
type
includ
immun
cell
util
receptor
receptor
present
immun
cell
includ
macrophag
merscov
infect
alter
innat
adapt
immun
respons
present
studi
demonstr
protein
merscov
glycoprotein
alter
macrophag
respons
render
hyporespons
stimul
find
indic
interact
merscov
protein
initi
signal
suppress
macrophag
activ
support
immunomodulatori
mechan
merscov
may
recent
evid
shown
infect
human
tcell
merscov
result
suppress
immun
respons
induc
intrins
extrins
apoptosi
pathway
provid
potenti
mechan
enhanc
pathogen
viru
group
shown
macrophag
also
infect
merscov
case
infect
viru
induc
product
thu
initi
antivir
respons
addit
evid
show
increas
sever
chemokin
product
macrophag
dendrit
cell
absenc
presenc
viral
replic
find
show
merscov
protein
induc
product
rather
capabl
suppress
induct
lp
suggest
induct
factor
observ
earlier
studi
due
activ
replic
viru
observ
sinc
case
macrophag
infect
activ
viru
inde
induct
neg
regul
macrophag
activ
irakm
occur
hour
follow
exposur
merscov
protein
suggest
viru
may
exert
proinflammatori
action
earli
stage
infect
follow
state
reduc
respons
proinflammatori
stimuli
effect
also
observ
primari
human
monocyt
irakm
induc
mrna
protein
level
induct
observ
protein
level
potenti
due
heterogen
pbmc
may
mask
effect
earlier
evid
shown
lack
result
increas
lethal
mice
infect
influenza
viru
ifluenza
viru
infect
induc
via
fatti
acid
bind
protein
suppress
immun
respons
support
crosstalk
viral
infect
innat
immun
respons
polymorph
associ
sustain
respons
hepat
c
viru
irakm
level
peripher
monocyt
macrophag
regul
inflammatori
respons
human
alveolar
macrophag
effect
viral
infect
irakm
express
previous
demonstr
analysi
genet
variant
irakm
perform
associ
system
lupu
erythematosu
associ
found
thu
result
provid
evid
crosstalk
irakm
viral
infect
support
earlier
find
effect
influenza
virus
express
function
find
support
merscov
glycoprotein
mediat
proinflammatori
oncotarget
wwwimpactjournalscomoncotarget
effect
observ
activ
viral
replic
addit
express
induc
macrophag
infect
lentivir
particl
carri
glycoprotein
data
shown
support
interact
merscov
glycoprotein
initi
signal
trigger
antivir
respons
find
demonstr
suppress
product
upon
lp
stimul
also
basal
level
macrophag
primari
human
monocyt
support
merscov
glycoprotein
induc
mechan
affect
tlr
signal
also
altern
pathway
control
cytokin
product
merscov
glycoprotein
also
induc
express
lpsactiv
macrophag
support
addit
mechan
suppress
immun
respons
thu
find
support
signal
initi
merscov
protein
render
macrophag
hyporespons
activ
signal
promot
immun
suppress
cell
viru
activ
prolifer
result
suppress
macrophag
respons
allow
viral
propag
suppress
capac
host
respond
opportunist
infect
thu
contribut
increas
mortal
merscov
infect
patient
macrophag
activ
regul
differ
level
factor
irakm
inact
homolog
irak
kinas
known
suppress
macrophag
activ
tlr
thu
render
hyporespons
proinflammatori
trigger
express
level
irakm
highlight
respons
regul
variou
factor
includ
lung
surfact
well
tlr
ligand
adipokin
present
report
demonstr
glycoprotein
mer
cov
induc
express
irakm
macrophag
provid
potenti
molecular
mechan
suppress
cytokin
product
induct
irakm
occur
hour
follow
infect
suggest
mer
glycoprotein
affect
late
respons
macrophag
may
provid
evid
immunosuppress
observ
later
stage
infect
respons
macrophag
also
regul
transcript
factor
transcript
repressor
suppress
transcript
proinflammatori
cytokin
result
show
merscov
glycoprotein
induc
express
provid
addit
molecular
mechan
immunosuppress
action
given
fact
express
macrophag
also
tcell
epitheli
cell
mechan
may
restrict
macrophag
glycoprotein
merscov
bind
receptor
allow
entri
host
cell
studi
show
interact
facilit
viral
entri
also
initi
signal
mediat
immunosuppress
action
allow
viru
propag
immunosuppress
may
account
increas
pathogen
viru
find
demonstr
inde
immunosuppress
action
glycoprotein
mediat
sinc
inhibit
sitagliptin
inhibitor
amelior
induct
irakm
sitagliptin
inhibitor
known
act
antidiabet
agent
revers
insulin
resist
yet
unknown
whether
individu
treatment
sitagliptin
less
suscept
merscov
infect
whether
produc
sever
symptom
diseas
moreov
find
may
propos
use
sitagliptin
potenti
treatment
patient
merscov
infect
sinc
may
revers
immunosuppress
action
viru
present
report
demonstr
novel
mechan
merscov
protein
action
suppress
macrophag
respons
via
induct
irakm
immunosuppress
cytokin
figur
effect
revers
inhibitor
sitagliptin
highlight
role
interact
pathogen
viru
provid
potenti
mean
revers
pathogen
merscov
infect
monocyt
cell
line
maintain
suspens
rpmi
medium
supplement
lglutamin
sodium
pyruv
fetal
bovin
serum
fb
antibiot
uml
penicillin
streptomycin
differenti
experi
cell
seed
final
densiti
cellsml
plate
cell
differenti
induc
ngml
phorbol
pma
sigmaaldrich
medium
differenti
adher
macrophag
use
infect
experi
peripher
blood
mononuclear
cell
pbmc
isol
buffi
coat
obtain
human
peripher
blood
healthi
donor
ficol
densiti
gradient
centrifug
monocyt
select
adher
plastic
rpmi
hour
product
lentivir
particl
pseudotyp
mer
glycoprotein
perform
previous
describ
briefli
human
immunodefici
viru
backbon
express
firefli
luciferas
cotransfect
cell
either
merscov
wildtyp
spike
glycoprotein
wwwimpactjournalscomoncotarget
wt
express
vector
invitrogen
mutant
spike
glycoprotein
vector
significantli
reduc
bind
consequ
viral
entri
figur
supernat
contain
lentivir
particl
pseudotyp
merscov
glycoprotein
harvest
h
later
subsequ
normal
use
elisa
kit
prior
infect
target
cell
rapid
titer
kit
takara
bio
usa
inc
amount
spike
glycoprotein
incorpor
differ
type
gener
viral
particl
pseudotyp
merscov
protein
determin
semiquantit
western
blot
purifi
viral
particl
ensur
equal
merscov
glycoprotein
express
among
infect
cell
lyse
h
infect
viral
entri
effici
quantifi
compar
luciferas
activ
pseudotyp
virus
either
express
merscov
glycoprotein
bear
mutant
wildtyp
merscov
glycoprotein
transient
transfect
perform
use
lipofectamin
reagent
rnaimax
life
technolog
per
manufactur
instruct
short
cell
pma
ad
seed
approxim
confluenc
next
day
silenc
rna
molecul
sirna
use
final
concentr
transfect
cell
cell
cultur
hour
presenc
transfect
reagent
prior
infect
lp
treatment
follow
prevalid
sirna
use
irakm
sirna
santacruz
sirna
santacruz
sirna
santacruz
silenc
neg
control
scr
sirna
ambion
detect
level
produc
cultur
cell
enzym
link
immunosorb
assay
ebiosci
detect
limit
cytokin
perform
indic
manufactur
previous
describ
cell
seed
confluenc
plate
repres
timepoint
hour
prior
endpoint
mtt
reagent
ad
per
cell
cultur
medium
endpoint
medium
remov
well
isopropanolhcl
ad
cell
cell
incub
minut
shaker
incub
od
measur
western
blot
cell
lysat
cell
harvest
use
mper
mammalian
protein
extract
reagent
thermo
scientif
rockford
il
usa
enrich
haltproteas
inhibitor
cocktail
edtafre
pierc
rockford
il
usa
accord
manufactur
instruct
previous
describ
protein
separ
polyacrylamid
gel
contain
sodiumdodecyl
sulphat
transfer
nitrocellulos
membran
merscov
glycoprotein
protein
express
vector
tag
tag
tetsqvapa
thu
antibodi
abnova
use
detect
protein
context
pseudovir
particl
pseudotyp
merscov
express
spike
glycoportein
migrat
pattern
viral
protein
present
two
major
band
high
molecular
weight
band
approxim
kda
low
molecular
weight
band
kda
accompani
faint
band
kda
previous
describ
detect
pparg
irakm
primari
antibodi
santa
cruz
biotechnolog
antiirakm
incub
membran
overnight
c
wash
pbst
tween
incub
hrpconjug
secondari
antibodi
hour
room
temperatur
visual
membran
perform
use
ecl
system
pierc
chemidoc
tm
xr
biorad
band
intens
protein
quantif
measur
use
imagelab
softwar
biorad
detect
mrna
level
irakm
pparg
total
rna
extract
macrophag
use
tri
reagent
sigma
life
scienc
previous
describ
briefli
cell
pellet
wash
pb
resuspend
tri
reagent
chlorophorm
ad
sampl
centrifug
x
g
c
min
centrifug
aqueou
phase
remov
transfer
new
tube
isopropanol
ad
precipit
rna
follow
wash
ethanol
pellet
dri
resuspend
rnasefre
water
one
microgram
total
dnasedigest
rna
use
cdna
synthesi
thermoscript
rt
invitrogen
carlsbad
ca
sybr
green
method
follow
pcr
reaction
primer
sequenc
follow
irakm
ggttctgctgaacaaaggca
tctccaagaaaactgagctgt
actinb
use
wwwimpactjournalscomoncotarget
refer
gene
gccgtgctgtccctctac
agcgcg
tagccctcataaat
denatur
carri
second
anneal
second
extens
second
cycl
statist
analysi
perform
use
graphpad
prism
version
window
graphpad
softwar
san
diego
california
usa
wwwgraphpadcom
p
valu
consid
indic
statist
signific
oneway
anova
ttest
analys
perform
